title: Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans.
abstract: Splanchnic and renal net balance measurements indicate that lactate and glycerol may be important precursors for epinephrine-stimulated gluconeogenesis (GNG) in liver and kidney, but the effects of epinephrine on their renal and hepatic conversion to glucose in humans have not yet been reported. We therefore used a combination of renal balance and isotopic techniques in nine postabsorptive volunteers to measure systemic and renal GNG from these precursors before and during a 3-h infusion of epinephrine (270 pmol. kg-1. min-1) and calculated hepatic GNG as the difference between systemic and renal rates. During infusion of epinephrine, renal and hepatic GNG from lactate increased 4- to 6-fold and accounted for approximately 85 and 70% of renal and hepatic glucose release, respectively, at the end of study; renal and hepatic GNG from glycerol increased approximately 1.5- to 2-fold and accounted for approximately 7-9% of renal and hepatic glucose release at the end of study. The increased renal GNG from lactate and glycerol was due not only to their increased renal uptake (approximately 3.3- and 1.4-fold, respectively) but also increased renal gluconeogenic efficiency (approximately 1.8- and 1.5-fold). The increased renal uptake of lactate and glycerol was wholly due to their increased arterial concentrations, since their renal fractional extraction remained unchanged and renal blood flow decreased. We conclude that 1) lactate is the predominant precursor for epinephrine-stimulated GNG in both liver and kidney, 2) hepatic and renal GNG from lactate and glycerol are similarly sensitive to stimulation by epinephrine, and 3) epinephrine increases renal GNG from lactate and glycerol by increasing substrate availability and the gluconeogenic efficiency of the kidney.
authors.affiliation: Department of Medicine, University of Roichester School of Medicine, Rochester, NY 14642, USA. christian.meyer@med.va.gov
authors.forename: Christian
authors.initials: C
authors.lastname: Meyer
authors.forename: Michael
authors.initials: M
authors.lastname: Stumvoll
authors.forename: Stephen
authors.initials: S
authors.lastname: Welle
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Woerle
authors.forename: Morey
authors.initials: M
authors.lastname: Haymond
authors.forename: John
authors.initials: J
authors.lastname: Gerich
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D004837:Epinephrine / Q000008:administration & dosage* / Q000097:blood; D005260:Female; D005943:Gluconeogenesis / Q000187:drug effects* / Q000502:physiology*; D005990:Glycerol / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D019344:Lactic Acid / Q000097:blood / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate
chemical_list: D001786:Blood Glucose; D007328:Insulin; D019344:Lactic Acid; D005990:Glycerol; D004837:Epinephrine